Company Profile
Public information reviewedALUMIS INC.
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.
USNASDAQ: ALMS
Follow
More
- Evidence records
- 2
- Published leadership records
- 8
- Record reviewed
- Sep 25, 2026

